Skip to main content
Premium Trial:

Request an Annual Quote

Oxford BioDynamics: Jon Burrows, Christian Hoyer Millar

Maryland-based Oxford BioDynamics has appointed Jon Burrows as group CEO, replacing Christian Hoyer Millar. Burrows currently works at consulting and clinical advisory firm Oncology Partners. He previously served as president and CEO of OncoPlex Diagnostics and as director of business development and interim head of Ventana Medical Systems' translational diagnostics business unit. After Roche acquired Ventana, Burrows served as director of pharma operations. 

Millar has served as OBD's CEO since cofounding the firm in 2007, and will now serve as executive chairman. 

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.